
浏览全部资源
扫码关注微信
衡水市人民医院手术室,河北 衡水 053000
常茹,E-mail:ge14122@163.com
纸质出版日期:2023-08-25,
收稿日期:2022-11-27,
扫 描 看 全 文
张森,常茹,郭超.腹腔镜手术联合抗感染及地诺孕素治疗子宫内膜异位症的临床研究[J].局解手术学杂志,2023,32(08):708-711.
.Clinical study of laparoscopic surgery combined with anti-infection and dienogest in the treatment of endometriosis[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(08):708-711.
张森,常茹,郭超.腹腔镜手术联合抗感染及地诺孕素治疗子宫内膜异位症的临床研究[J].局解手术学杂志,2023,32(08):708-711. DOI: 10.11659/jjssx.11E022145.
.Clinical study of laparoscopic surgery combined with anti-infection and dienogest in the treatment of endometriosis[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(08):708-711. DOI: 10.11659/jjssx.11E022145.
目的
2
探析腹腔镜手术联合术后抗感染及地诺孕素三联策略在子宫内膜异位症(EMs)中的应用效果。
方法
2
选择于本院就诊的90例EMs患者,采用随机数表法分为观察组和对照组,每组45例。2组均使用腹腔镜手术联合术后抗感染治疗策略,观察组在此基础上联合地诺孕素持续治疗3个月。对比2组症状改善率、手术前后子宫内膜异位症生育指数(EFI)、细胞因子[高迁移率族蛋白1(HMGB1)、纤维蛋白原(FIB)、转化生长因子β1(TNF-β1)]表达水平、输卵管通畅率、妊娠率、复发率、不良反应发生率。
结果
2
观察组症状改善率高于对照组(
P
<
0.05)。观察组术后EFI高于对照组(
P
<
0.05),HMGB1、FIB、TNF-β1水平低于对照组(
P
<
0.05)。观察组术后输卵管通畅率、妊娠率高于对照组(
P
<
0.05),复发率低于对照组(
P
<
0.05);2组不良反应发生率比较差异无统计学意义(
P
>
0.05)。
结论
2
基于腹腔镜手术联合术后抗感染及地诺孕素的三联策略治疗EMs的临床效果显著,可有效提高EFI、输卵管通畅率、妊娠率,纠正HMGB1、FIB、TNF-β1等细胞因子水平,降低复发率,安全性较高。
Objective
2
To explore the efficacy of laparoscopic surgery combined with postoperative anti-infection and dienogest in endometriosis (EMs).
Methods
2
A total of 90 patients with EMs were selected and divided into the observation group and the control group by random number table method, with 45 cases in each group.Both groups were treated with laparoscopic surgery combined with postoperative anti-infective treatment strategy, and the observation group continued to treat with dienogest for 3 months.The symptom improvement rates, endometriosis fertility index (EFI) before and after surgery, expression levels of cytokine [high mobility groupbox-1 (HMGB1), fibrinogen (FIB), and transforming growth factor beta 1 (TNF-β1)], tubal patency rate, pregnancy rate, recurrence rate, and incidence of adverse reactions.
Results
2
The symptom improvement rate of the observation group was higher than that of the control group (
P
<
0.05).The EFI after surgery of the observation group was higher than that of the control group (
P
<
0.05),the levels of HMGB1, FIB, TNF-β1 were lower than those in the control group (
P
<
0.05).The tubal patency rate and pregnancy rate after surgery of the observation group were higher than those of the control group(
P
<
0.05), and the recurrence rate was lower than that of the control group (
P
<
0.05).There was no significant difference in the incidence of adverse reactions between the two groups (
P
>
0.05).
Conclusion
2
The triple strategy of laparoscopic surgery combined with postoperative anti-infection and dienogest has significant clinical effect in the treatment of EMs, which can effectively improve the EFI, tubal patency rate, and pregnancy rate, and correct the levels of cytokines such as HMGB1, FIB, TNF-β1, and reduce the recurrence rate, with high safety.
腹腔镜手术抗感染地诺孕素子宫内膜异位症输卵管通畅率妊娠率
laparoscopic surgeryanti-infectiondienogestendometriosistubal patency ratepregnancy rate
Smolarz B,Szyłło K,Romanowicz H.Endometriosis:epidemiology,classification,pathogenesis,treatment and genetics (review of literature)[J].Int J Mol Sci,2021,22(19):10554.doi:10.3390/ijms221910554http://dx.doi.org/10.3390/ijms221910554.
聂伟哲,李舒婷,Zondervan KT,等.中国和英国子宫内膜异位症患者的发病相关因素分析[J].南方医科大学学报,2022,42(1):137-142.doi:10.17816/jowd58194-42617http://dx.doi.org/10.17816/jowd58194-42617.
张彬彬,刘晶晶,李丹,等.腹腔镜联合小金胶囊及亮丙瑞林治疗子宫内膜异位症临床评价[J].中国药业,2020,29(6):128-131.doi:10.26549/yzlcyxzz.v3i7.6217http://dx.doi.org/10.26549/yzlcyxzz.v3i7.6217.
Bafort C,Beebeejaun Y,Tomassetti C,et al.Laparoscopic surgery for endometriosis[J].Cochrane Database Syst Rev,2020,10(10):CD011031.doi:10.1002/14651858http://dx.doi.org/10.1002/14651858.
庞海霞,孙静莉.腹腔镜手术联合戈舍瑞林缓释植入剂治疗子宫内膜异位症合并不孕症3年随访观察[J].中国计划生育学杂志,2021,29(3):452-456.doi:10.12677/acm.2020.107227http://dx.doi.org/10.12677/acm.2020.107227.
Malik R,Mann MK.Role of dienogest in endometriosis in young women[J].Obstet Gynaecol India,2021,71(5):522-529.doi:10.1007/s13224-021-01483-0http://dx.doi.org/10.1007/s13224-021-01483-0.
段利利,李志斌,张婵,等.地诺孕素在子宫内膜异位症中的治疗效果[J].中国妇幼健康研究,2021,32(6):909-913.doi:10.3969/j.issn.1673-5293.2021.06.024http://dx.doi.org/10.3969/j.issn.1673-5293.2021.06.024.
中国医师协会妇产科医师分会,中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症诊治指南(第三版)[J].中华妇产科杂志,2021,56(12):812-824.doi:10.17816/jowd58194-42617http://dx.doi.org/10.17816/jowd58194-42617.
Rolla E.Endometriosis:advances and controversies in classification,pathogenesis,diagnosis,and treatment[J].F1000Res,2019,8:F1000 Faculty Rev-529.doi:10.12688/f1000research.14817.1http://dx.doi.org/10.12688/f1000research.14817.1.
张屹立,许泓.慢性应激和子宫内膜异位症的研究进展[J].中国计划生育和妇产科,2022,14(1):33-36.doi:10.17816/jowd58194-42617http://dx.doi.org/10.17816/jowd58194-42617.
于玲玉,孙振高.子宫内膜异位症的免疫学发病机制研究现状[J].中国生育健康杂志,2021,32(2):187-189.doi:10.12677/acm.2023.132374http://dx.doi.org/10.12677/acm.2023.132374.
Ceccaroni M,Clarizia R,Liverani S,et al.Dienogest vs. GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery:a randomized controlled trial[J].Gynecol Endocrinol,2021,37(10):930-933.doi:10.1080/09513590.2021.1929151http://dx.doi.org/10.1080/09513590.2021.1929151.
王晓平.不同手术方式对子宫内膜异位伴不孕症患者卵巢储备功能和妊娠率影响的比较[J].南昌大学学报(医学版),2017,57(2):65-68.doi:10.17816/jowd58194-42617http://dx.doi.org/10.17816/jowd58194-42617.
孙红娟.腹腔镜手术治疗子宫内膜异位症的临床疗效[J].医学临床研究,2019,36(7):1388-1390.doi:10.26549/yzlcyxzz.v3i7.6217http://dx.doi.org/10.26549/yzlcyxzz.v3i7.6217.
于晓川,朱芳,吴丹丹.GnRH-a用于中、重度子宫内膜异位症腹腔镜手术后对妊娠的影响[J].中国计划生育学杂志,2022,30(1):42-45.doi:10.17816/jowd58194-42617http://dx.doi.org/10.17816/jowd58194-42617.
梁秀文,季新梅.腹腔镜治疗子宫内膜异位症合并不孕症的疗效及影响术后妊娠的因素[J].医学临床研究,2017,34(4):711-714.doi:10.26549/yzlcyxzz.v3i7.6217http://dx.doi.org/10.26549/yzlcyxzz.v3i7.6217.
郑红梅,李伶,盛天驰,等.卵巢子宫内膜异位囊肿腹腔镜术后自然妊娠影响因素分析[J].中国计划生育学杂志,2022,30(4):824-827.doi:10.12677/ns.2019.86075http://dx.doi.org/10.12677/ns.2019.86075.
张艳,钱慧,蔡燕,等.子宫内膜异位症合并下生殖道感染患者外周血Th17/T reg和血清细胞因子变化[J].中华医院感染学杂志,2020,30(16):2511-2514.doi:10.17816/jowd64892-42614http://dx.doi.org/10.17816/jowd64892-42614.
Mehdizadeh Kashi A,Niakan G,Ebrahimpour M,et al.Arandomized,double-blind,placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis[J].Int J Gynaecol Obstet,2022,156(1):124-132.doi:10.1002/ijgo.13677http://dx.doi.org/10.1002/ijgo.13677.
Murji A,Biberoğlu K,Leng J,et al.Use of dienogest in endometriosis:a narrative literature review and expert commentary[J].Curr Med Res Opin,2020,36(5):895-907.doi:10.1080/03007995.2020.1744120http://dx.doi.org/10.1080/03007995.2020.1744120.
郑韵熹,易晓芳,徐丛剑.地诺孕素在子宫内膜异位症治疗中的应用研究进展[J].中华生殖与避孕杂志,2020,40(10):828-831.doi:10.3760/cma.j.issn.2096-2916.2020.0029http://dx.doi.org/10.3760/cma.j.issn.2096-2916.2020.0029..
徐冰,李华军,贾婉璐,等.地诺孕素用于难治性子宫内膜异位症疼痛的临床研究[J].中华妇产科杂志,2021,56(3):178-184.doi:10.3760/cma.j.cn112141-20200525-00444http://dx.doi.org/10.3760/cma.j.cn112141-20200525-00444.
陈静,陆晓媛.高迁移率族蛋白B1和程序性坏死在子宫内膜异位症中的作用[J].中国临床研究,2020,33(4):446-451.doi:10.13429/j.cnki.cjcr.2020.04.004http://dx.doi.org/10.13429/j.cnki.cjcr.2020.04.004.
王小兰,李美,童天夫,等.中重度子宫内膜异位症患者凝血指标、血清炎症因子变化及其临床意义[J].中国计划生育学杂志,2022,30(1):129-134.doi:10.3969/j.issn.1004-8189.2022.01.030http://dx.doi.org/10.3969/j.issn.1004-8189.2022.01.030.
亓文博,张明乐,黄向华.腹腔镜保守性手术联合药物治疗中、重度子宫内膜异位症及地诺孕素治疗复发性子宫内膜异位症性盆腔痛的疗效分析[J].中华生殖与避孕杂志,2017,37(5):384-388.doi:10.3760/cma.j.issn.2096-2716.2017.05.008http://dx.doi.org/10.3760/cma.j.issn.2096-2716.2017.05.008.
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621